- Home
- CFFI vs NBTX Comparison
CFFI vs NBTX Comparison
Compare CFFI & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- NBTX
- Stock Information
- Founded
- CFFI 1927
- NBTX 2003
- Country
- CFFI United States
- NBTX France
- Employees
- CFFI N/A
- NBTX N/A
- Industry
- CFFI Major Banks
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- CFFI Finance
- NBTX Health Care
- Exchange
- CFFI Nasdaq
- NBTX Nasdaq
- Market Cap
- CFFI 248.5M
- NBTX 201.9M
- IPO Year
- CFFI 1998
- NBTX 2020
- Fundamental
- Price
- CFFI $72.50
- NBTX $3.26
- Analyst Decision
- CFFI
- NBTX Strong Buy
- Analyst Count
- CFFI 0
- NBTX 1
- Target Price
- CFFI N/A
- NBTX $12.00
- AVG Volume (30 Days)
- CFFI 12.4K
- NBTX 64.6K
- Earning Date
- CFFI 01-22-2025
- NBTX 12-31-2024
- Dividend Yield
- CFFI 2.41%
- NBTX N/A
- EPS Growth
- CFFI N/A
- NBTX N/A
- EPS
- CFFI 5.66
- NBTX N/A
- Revenue
- CFFI $114,783,000.00
- NBTX $45,220,186.00
- Revenue This Year
- CFFI N/A
- NBTX N/A
- Revenue Next Year
- CFFI N/A
- NBTX N/A
- P/E Ratio
- CFFI $12.89
- NBTX N/A
- Revenue Growth
- CFFI N/A
- NBTX 526.17
- 52 Week Low
- CFFI $33.51
- NBTX $2.76
- 52 Week High
- CFFI $80.87
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- CFFI 44.28
- NBTX 42.55
- Support Level
- CFFI $76.31
- NBTX $3.18
- Resistance Level
- CFFI $80.87
- NBTX $3.69
- Average True Range (ATR)
- CFFI 2.94
- NBTX 0.27
- MACD
- CFFI -1.07
- NBTX 0.07
- Stochastic Oscillator
- CFFI 14.95
- NBTX 56.45
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum revenue from the Community Banking segment.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.